Strategy for research development of therapeutic agents for autoimmune diseases
Fujitani, Y.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 57
2013
ISSN/ISBN: 0015-5691 PMID: 24344398 Document Number: 671282
Document emailed within 1 workday
Related Documents
Eto, S.; Fujihira, T. 1988: Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and the therapeutic methods. Organ-specific autoimmune diseases. 1) Autoimmune thyroid diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 894-900Nagasawa, T. 1988: Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and the therapeutic methods. Organ-specific autoimmune diseases. 5) Anti-GBM antibody diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 918-924
Azuma, T. 1988: Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 4) Rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 883-887
Lewis, N.J. 1985: The design and development of therapeutic agents for neuromuscular diseases Progress in Clinical and Biological Research 197: 105-110
Ichikawa, Y.; Tsunematsu, T.; Yokohari, R.; Tanimoto, K.; Sakane, T.; Yoshida, H.; Kano, S.; Sawada, S.; Hashimoto, H.; Nagasawa, T. 1985: Multicenter study of causes of death in systemic lupus erythematosus-a report from the Subcommittee for Development of Therapy, the Research Committee for Autoimmune Diseases Supported by the Ministry of Health and Welfare Ryumachi 25(4): 258-264
Ohata, K.; Kohno, S. 1987: Progress of therapeutic agents for asthma--3) Trends in the development of leukotriene inhibitory agents Nihon Rinsho. Japanese Journal of Clinical Medicine 45(8): 1843-1852
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Goldman, M. 1994: New therapeutic strategies for cell-mediated autoimmune diseases Acta Neurologica Belgica 94(2): 89-91
Ndiaye, M.R.; Sarr, M.H.; Ba, E.A.; Ndoye, P.A.; Seye-Ndiaye, C.; Ndiaye, P.A.; Wade, P.A. 1996: Corneal marginal ulcer. Autoimmune diseases, new therapeutic aspects Dakar Medical Spec No: 35-37
Liu, T-Chi; Chen, Y-Jen 2010: Research and development investment strategy and market performance Social Behavior and Personality An International Journal 38(2): 227-236
Slavin, S. 1993: Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT Bone Marrow Transplantation 12(1): 85-88
Read, S. 1994: The Strategy for Research in Nursing in England: Initial impact In May 1993, the Department of Health published The Report of the Taskforce on the Strategy for Research in Nursing, Midwifery and Health Visiting ( 1 ). The Taskforce had been appointed to consider the scope and objectives of research in England and the interfaces with other areas of health services research. Susan Read reports on its progress Nurse researcher 1(3): 72-84
Read, S. 1994: The Strategy for Research in Nursing in England: Initial impact In May 1993, the Department of Health published The Report of the Taskforce on the Strategy for Research in Nursing, Midwifery and Health Visiting ( 1 ). The Taskforce had been appointed to consider the scope and objectives of research in England and the interfaces with other areas of health services research. Susan Read reports on its progress Nurse researcher 1(3): 72-84
Hannaford, P.; Hunt, J.; Sullivan, F.; Wyke, S. 1999: Shaping the future: a primary care research and development strategy for Scotland Health Bulletin 57(5): 295-299
Novick, D.M. 1991: Corticosteroids as therapeutic agents in liver diseases American Journal of Gastroenterology 86(1): 30-32
Gaebel, W.; Maier, W. 1993: Neurobiological determinants of schizophrenic diseases. Concept, strategy and methods of a research program Der Nervenarzt 64(7): 415-426
Wada, T.; Matsui, H. 2013: Research development of novel antineoplastic agents Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
Solberg, L.A. 2005: Biologic aspects of thrombopoietins and the development of therapeutic agents Current Hematology Reports 4(6): 423-428
Kimura, H. 2013: Impact Goals of Research and Development Technology on the Business Strategy of NTT's Fiber-to-the-Home Deployment Fiber Optics in Access Network Workshop (3 ; St. Petersburg 2012-10) 32(1-6): 75-92
Tafreshi, M.J.; Weinacker, A.B. 1999: Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma PharmacoTherapy 19(8): 974-978